Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_assertion description "[Because NF-kappaB is considered to be a factor in the augmentation of malignant properties of cells, treatment of tumors with 5-dAzaC, TSA, and NaBu may provide a novel approach to the enhancement of therapeutic effects of glucocorticoids in epithelial carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_assertion evidence source_evidence_literature NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_assertion SIO_000772 19427965 NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_assertion wasDerivedFrom befree-20140225 NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_assertion wasGeneratedBy ECO_0000203 NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP181266.RAnYU6f-2bXMG5zwi52aTLq2KlfmPRsXwLedL_zDaaF8M130_provenance.